Abstract
In view of previous findings that crude, and particularly desialylated, forms of hCG are capable of inhibiting the increase in cAMP concentrations induced in human thyroid membranes by TSH, we have conducted experiments to determine whether hCG is capable of inhibiting the response to the stimulatory immunoglobulins of Graves' disease (G-IgG). Preparations studied were crude hCG (hCG-c; 2500 IU/mg), pure hCG (hCG-p; 13,400 IU/mg), and desialylated derivatives thereof. Slices of normal human thyroid were employed as the target tissue, and an increase in the tissue cAMP concentration was used as the index of response. G-IgG were prepared from the pooled sera of patients with untreated Graves'disease by means of chromatography on columns of staphylococcal protein A-Sepharose. Up to a concentration of 20 mg/ml, increasing concentrations of G-IgG increased tissue cAMP concentrations in a dose-dependent manner. When 10 mg G-IgG and 1.2 mg hCG-c were incubated together, a highly significant inhibition of the res...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: The Journal of clinical endocrinology and metabolism
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.